BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19374269)

  • 21. Trends in the prevalence of trachoma, South Australia, 1976 to 1990.
    Stocks NP; Hiller JE; Newland H; McGilchrist CA
    Aust N Z J Public Health; 1996 Aug; 20(4):375-81. PubMed ID: 8908760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of effects of community intervention with antibiotics, facial cleanliness, and environmental improvement (A,F,E) in five districts of Ethiopia hyperendemic for trachoma.
    Ngondi J; Gebre T; Shargie EB; Adamu L; Teferi T; Zerihun M; Ayele B; King JD; Cromwell EA; Emerson PM
    Br J Ophthalmol; 2010 Mar; 94(3):278-81. PubMed ID: 19897474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Trachoma in Chad: results of an epidemiological survey].
    Madani MO; Huguet P; Mariotti SP; Dézoumbé D; Tosi C; Djada D; Negrel AD
    Sante; 2003; 13(1):9-15. PubMed ID: 12925317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between Community Drug Administration Strategy and Changes in Trachoma Prevalence, 2007 to 2013.
    Liu B; Cowling C; Hayen A; Watt G; Mak DB; Lambert S; Taylor H; Kaldor JM
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004810. PubMed ID: 27385309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of trachoma in Aboriginal communities in the Katherine Region of the Northern Territory in 2007.
    Roper K; Michel CE; Kelly PM; Taylor HR
    Med J Aust; 2008 Oct; 189(7):409. PubMed ID: 18837687
    [No Abstract]   [Full Text] [Related]  

  • 26. Barriers to the implementation of the SAFE strategy to combat hyperendemic trachoma in Australia.
    Wright HR; Keeffe JE; Taylor HR
    Ophthalmic Epidemiol; 2010 Dec; 17(6):349-59. PubMed ID: 21090909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of face washing and environmental improvement on reduction of active trachoma in Vietnam-a public health intervention study.
    Khandekar R; Ton TK; Do Thi P
    Ophthalmic Epidemiol; 2006 Feb; 13(1):43-52. PubMed ID: 16510346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achieving trachoma control in Ghana after implementing the SAFE strategy.
    Yayemain D; King JD; Debrah O; Emerson PM; Aboe A; Ahorsu F; Wanye S; Ansah MO; Gyapong JO; Hagan M
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):993-1000. PubMed ID: 19286239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of trachoma among a group of Aboriginal school children in remote South Australia.
    Durkin SR; Casson RJ; Selva D; Newland HS
    Clin Exp Ophthalmol; 2006 Aug; 34(6):628-9. PubMed ID: 16925722
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral health comparisons between children attending an Aboriginal health service and a Government school dental service in a regional location.
    Parker EJ; Jamieson LM
    Rural Remote Health; 2007; 7(2):625. PubMed ID: 17474830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology of trachoma in the five northern districts of Sierra Leone.
    Koroma JB; Heck E; Vandy M; Sonnie M; Hodges M; MacArthur C; Sankara DP
    Ophthalmic Epidemiol; 2011 Aug; 18(4):150-7. PubMed ID: 21780873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active trachoma, face washing (F) and environmental improvement (E) in a high-risk population in Oman.
    Khandekar R; Mabry R; Al Hadrami K; Sarvanan N
    East Mediterr Health J; 2005 May; 11(3):402-9. PubMed ID: 16602460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A targeted, single-dose azithromycin strategy for trachoma.
    Laming AC; Currie BJ; DiFrancesco M; Taylor HR; Mathews JD
    Med J Aust; 2000 Feb; 172(4):163-6. PubMed ID: 10772587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of trachoma prevalence in a mobile population in Central Australia.
    Lansingh VC; Weih LM; Keeffe JE; Taylor HR
    Ophthalmic Epidemiol; 2001 Jul; 8(2-3):97-108. PubMed ID: 11471079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trachoma prevalence in Niger: results of 31 district-level surveys.
    Cromwell EA; Amza A; Kadri B; Beidou N; King JD; Sankara D; Mosher AW; Hassan S; Kane S; Emerson PM
    Trans R Soc Trop Med Hyg; 2014 Jan; 108(1):42-8. PubMed ID: 24281748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epidemiology of blindness and trachoma in the Anangu Pitjantjatjara of South Australia.
    Stocks NP; Newland H; Hiller J
    Med J Aust; 1994 Jun; 160(12):751-6. PubMed ID: 8208190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of three years of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness and Environmental improvement) for trachoma control in five districts of Ethiopia hyperendemic for trachoma.
    Ngondi J; Gebre T; Shargie EB; Adamu L; Ejigsemahu Y; Teferi T; Zerihun M; Ayele B; Cevallos V; King J; Emerson PM
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1001-10. PubMed ID: 19178920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the prevalence of trachoma 12 years after baseline surveys in Kidal Region, Mali.
    Bamani S; Dembele M; Sankara D; Coulibaly F; Kamissoko Y; Ting J; Rotondo LA; Emerson PM; King JD
    Trop Med Int Health; 2010 Mar; 15(3):306-11. PubMed ID: 20070630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.